6/12/2025

The PGIM Jennison Health Sciences Fund lost value, underperforming its benchmark Index during the Q1 of 2025. Click here to read the full commentary.

Source: SeekingAlpha

6/11/2025

During Q1, the Embark Small Cap Equity Fund delivered a total return of -10.53%, underperforming the benchmark, the Russell 2000® Index, which returned -9.48%.

Source: SeekingAlpha

6/10/2025

Presenter SpeechUnknown Analyst All right. Great. Let's kick off our next session. Very pleased to have the management team of Vaxcyte here with us, Grant Pickering, CEO; and Andrew Guggenhime,

Source: Finnhub

6/10/2025

Explore an updated analysis of Vaxcyte, Inc., its promising vaccine candidates, market sentiment shift, and financial strength. Click for my PCVX update.

Source: SeekingAlpha

6/6/2025

During the first quarter, the Harbor Health Care ETF returned 2.18% (NAV), outperforming the Russell 3000® Growth Health Care Index, which returned 1.99%.

Source: SeekingAlpha

6/4/2025

Source: SeekingAlpha

5/31/2025

Source: SeekingAlpha

5/30/2025

Source: SeekingAlpha

5/28/2025

Small-cap stocks experienced a broad drawdown in Q1 with the Russell 2000® Growth Index (down 11.12%) trailing the Russell 2000® Value Index (down 7.74%) by a notable margin.

Source: SeekingAlpha

5/27/2025

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Small-cap stocks experienced a significant drop in Q1, with the Russell 2000 Growth Index (down 11.12%) trailing the Russell 2000 Value Index (down 7.74%). In the […]

Source: Yahoo

5/22/2025

In the first quarter, the Lazard US Equity Concentrated Portfolio underperformed its benchmark, the S&P 500 Index. Read more here.

Source: SeekingAlpha

5/20/2025

Janus Henderson Forty Fund returned -8.74% and the Russell 1000® Growth Index returned -9.97%. Read more here.

Source: SeekingAlpha

5/20/2025

The Portfolio returned 1.36% (gross) and the MSCI World Health Care Index SM returned 5.29%.

Source: SeekingAlpha

5/20/2025

Source: SeekingAlpha

5/20/2025

Concentrated All Cap Growth Managed Account returned -9.25% (gross) and the Russell 3000® Growth Index returned -10.05%. Read more here.

Source: SeekingAlpha

5/11/2025

Source: SeekingAlpha

5/9/2025

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Vaxcyte, Inc. (NASDAQ:PCVX) stands against the other stocks that will bounce back. Major US indexes finished in the green on Wednesday, May 7, after a volatile session […]

Source: Yahoo

5/8/2025

Presenter SpeechJason Gerberry First off, my name is Jason Gerberry. I'm one of the mid-cap biotech analysts at BofA. I'm pleased to be introducing Vaxcyte's Andrew Guggenhime, Chief Financial...

Source: Finnhub

5/7/2025

-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 2 Dose-Finding Study of VAX-24 in Healthy Infants; Balance of Data Expected by End of 2025 -- -- Initiated Second and Final Stage of VAX-31 Infant Phase 2 Dose-Finding Study; Topline Safety, Tolerability and Immunogenicity Data from Primary Three-Dose Immunization Series Expected in Mid-2026, With Complete Booster Data Up to Nine Months Later -- -- Company Expects to Initiate VAX-31 Adult Phase 3 Pivotal

Source: Yahoo

5/7/2025

For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary.

Source: SeekingAlpha